Company news from the 02/20/07 News Brief

Share this article:
GfK Market Measures has established a dedicated business unit and appointed senior industry expert in oncology, Bill Bowman, to lead the company's strategic efforts in this area of research. In his new role as VP of oncology at GfK Market Measures, Bowman, who has more than 15 years of oncology experience, will be responsible for developing syndicated products for oncology and serve as a key in-house resource for custom marketing research studies involving cancer therapies.
Share this article:

Email Newsletters

More in News

Meaningful use not linked to quality: study

Meaningful use not linked to quality: study

A recent study of physicians found no correlation between following EHR meaningful use requirements and providing consistently higher quality of care.

Lilly Q1 sales dip

Lilly Q1 sales dip

US sales fell 34% during the quarter, largely due to lower demand and lower prices for off-patent Cymbalta and Evista.

Gilead reaps huge HCV sales, payer fury

Gilead reaps huge HCV sales, payer fury

Sovaldi's debut has been marked by plenty of criticism from payers and lawmakers, but the hep. C drug's launch, now confirmed to be the fastest of all time, has also ...